Summary of Purpose
The purpose of this study is to determine whether NA-1 is effective in reducing global disability in patients with acute cerebral ischemia if administered early after symptom onset.Read More →
The following dates are available for this trial. Trial information last updated on 27 October 2017.
|26 Mar 2015||5 Dec 2014||31 Mar 2019||31 May 2019||1 Oct 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Sponsors See All
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Jim Christenson, M.D.
- Laurie J Morrison, M.D.